StockVS

HealthEquity, Inc. (HQY) 주식 분석

의료

HealthEquity, Inc.

$87.25

$-0.86 (-0.98%)

최종 업데이트: 2026년 5월 26일

가격 추이

최신 뉴스

제3자 소스에서 제공된 뉴스입니다. 투자 조언이 아닙니다.

분석

회사 개요

HealthEquity, Inc. operates as a provider of technology-enabled services platforms, delivering health savings accounts and automated investment advisory tools to consumers and employers across the United States. The company functions within the healthcare sector, specifically specializing in the health information services industry, which focuses on managing and optimizing financial benefits related to health care. Its current market capitalization stands at $7.19B, supported by a trailing twelve-month revenue of $1.31B and an employee base of 2,814 individuals. These valuation and revenue figures indicate that the firm holds a substantial position in its niche, reflecting significant market recognition and operational scale within the specialized health information services landscape.

재무 건전성

The company reported a revenue of $1.31B for the trailing twelve months, generating a net income of $215.20M and an EBITDA of $482.14M, revealing a cost structure where operating expenses and taxes consume a significant portion of top-line growth. The EBITDA figure of $482.14M stands nearly double the net income, highlighting the impact of interest and tax obligations on the bottom line. Free cash flow amounts to $338.05M, providing the firm with considerable financial flexibility to fund operations, reduce debt, or pursue strategic opportunities without immediate reliance on external financing. The gross margin is recorded at 69.5%, while the operating margin sits at 21.6% and the profit margin at 16.4%, indicating a business model with high initial value capture that is subsequently reduced by substantial operating costs and taxes. On the balance sheet, the company holds $318.93M in cash against $1.00B in debt, resulting in a debt-to-equity ratio of 47.53%, which suggests a leveraged capital structure rather than a conservative, cash-heavy stance. Despite the debt load, the current ratio of 3.27 demonstrates robust short-term liquidity, as current assets are more than three times current liabilities. Management effectiveness is further evidenced by a return on equity of 10.2% and a return on assets of 6.0%, showing that the company generates moderate returns on the capital invested by shareholders and utilized in its operations.

밸류에이션 평가

Valuation metrics reveal a trailing P/E ratio of 34.23 compared to a forward P/E of 15.76, implying that the market expects a dramatic expansion in earnings over the coming year that would significantly compress the multiple. The price-to-book ratio is 3.40, suggesting the stock trades at a substantial premium over its book value, reflecting intangible assets or growth expectations not captured on the balance sheet. Alternative valuation measures such as a price-to-sales ratio of 5.48 and an EV/EBITDA of 16.17 provide additional context, indicating that investors are willing to pay a high multiple for the company's revenue generation and earnings power. The stock has historically traded between a 52-week high of $116.65 and a 52-week low of $72.76, with recent price action often fluctuating within this wide range that reflects the market's reaction to earnings volatility. The beta value of 0.26 indicates that the stock exhibits low price volatility relative to the broader market, moving with significantly less intensity than the overall index.

Growth & Income

Revenue growth for the trailing twelve months stands at 7.3%, while earnings growth reaches 92.4%, demonstrating that profitability is expanding at a rate far exceeding top-line sales growth. This divergence implies that recent earnings increases are likely driven by margin expansion, cost efficiencies, or one-time items rather than pure volume increases. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, all generated earnings are retained and reinvested directly into business growth and capital expenditures. Consequently, the overall growth and income profile is characterized by aggressive earnings acceleration funded entirely through internal retention rather than shareholder distributions.

동종업체 비교

HealthEquity, Inc. (HQY) 은(는) 의료 정보 서비스 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
HealthEquity, Inc. HQY $7.31B 35.5
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A

의료 정보 서비스 산업 평균 PER은 57.5배입니다. HealthEquity, Inc.의 PER은 35.5입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

HealthEquity, Inc. 소개

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$7.31B
PER
35.47
52주 최고가
$116.65
52주 최저가
$72.76
평균 거래량
953.28K
베타
0.19

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NASDAQ
국가
United States
직원 수
2,814